Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick B Meeker

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Medicinal Chemistry|May 2, 2023
<i>N</i>-Phenyl-1-(phenylsulfonyl)-1<i>H</i>-1,2,4-triazol-3-amine as a New Class of HIV-1 Non-nucleoside Reverse Transcriptase InhibitorThomas Lane, Vadim Makarov, Julie A E Nelson, et al.
Cell Reports|April 28, 2021
Tau seeds are subject to aberrant modifications resulting in distinct signaturesJui-Heng Tseng, Aditi Ajit, Zarin Tabassum, et al.
Iscience|June 26, 2020
The Accumulation of Tau-Immunoreactive Hippocampal Granules and Corpora Amylacea Implicates Reactive Glia in Tau Pathogenesis during AgingConnor M Wander, Jui-Heng Tseng, Sheng Song, et al.
Experimental Neurology|March 19, 2021
GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegenerationDouglas J Hermes, Barkha J Yadav-Samudrala, Changqing Xu, et al.
Journal of Neuroinflammation|November 19, 2020
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acidsDouglas J Hermes, Ian R Jacobs, Megan C Key, et al.
Iscience|June 16, 2025
ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activationBaggio A Evangelista, Joey V Ragusa, Kyle Pellegrino, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Medicinal Chemistry|May 2, 2023
<i>N</i>-Phenyl-1-(phenylsulfonyl)-1<i>H</i>-1,2,4-triazol-3-amine as a New Class of HIV-1 Non-nucleoside Reverse Transcriptase InhibitorThomas Lane, Vadim Makarov, Julie A E Nelson, et al.
Cell Reports|April 28, 2021
Tau seeds are subject to aberrant modifications resulting in distinct signaturesJui-Heng Tseng, Aditi Ajit, Zarin Tabassum, et al.
Iscience|June 26, 2020
The Accumulation of Tau-Immunoreactive Hippocampal Granules and Corpora Amylacea Implicates Reactive Glia in Tau Pathogenesis during AgingConnor M Wander, Jui-Heng Tseng, Sheng Song, et al.
Experimental Neurology|March 19, 2021
GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegenerationDouglas J Hermes, Barkha J Yadav-Samudrala, Changqing Xu, et al.
Journal of Neuroinflammation|November 19, 2020
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acidsDouglas J Hermes, Ian R Jacobs, Megan C Key, et al.
Iscience|June 16, 2025
ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activationBaggio A Evangelista, Joey V Ragusa, Kyle Pellegrino, et al.
Pageof 5